Cargando…

A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction

A 76-year-old woman was admitted to the emergency room of Nagano Municipal Hospital with the complain of severe back pain. Chest and abdominal enhanced computed tomography scans showed bilateral adrenal infarction and minute pulmonary nodules, but she had no respiratory symptoms. After admission, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Asano, Yuki, Koshi, Tomomichi, Sano, Asami, Maruno, Takashi, Kosaka, Makoto, Yamazaki, Yoshitaka, Oiwa, Ako, Nishii, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648520/
https://www.ncbi.nlm.nih.gov/pubmed/34916731
http://dx.doi.org/10.18999/nagjms.83.4.883
_version_ 1784610823345274880
author Asano, Yuki
Koshi, Tomomichi
Sano, Asami
Maruno, Takashi
Kosaka, Makoto
Yamazaki, Yoshitaka
Oiwa, Ako
Nishii, Yutaka
author_facet Asano, Yuki
Koshi, Tomomichi
Sano, Asami
Maruno, Takashi
Kosaka, Makoto
Yamazaki, Yoshitaka
Oiwa, Ako
Nishii, Yutaka
author_sort Asano, Yuki
collection PubMed
description A 76-year-old woman was admitted to the emergency room of Nagano Municipal Hospital with the complain of severe back pain. Chest and abdominal enhanced computed tomography scans showed bilateral adrenal infarction and minute pulmonary nodules, but she had no respiratory symptoms. After admission, a family member of the patient was found to have been in close contact with a coronavirus disease 2019 (COVID-19) patient. Thus, polymerase chain reaction and antigen tests of severe acute respiratory syndrome coronavirus 2 were conducted, and both tests returned positive. D-dimer levels were normal on admission but increased 2 days thereafter. Anticoagulation therapy and steroid replacement were started, and the patient improved over about two weeks. One month after the onset of adrenal infarction, a rapid adrenocorticotropic hormone loading test was conducted, which revealed that the primary adrenal insufficiency due to adrenal infarction might have been caused by the COVID-19 infection. This case was rare and suggestive of adrenal infarction with COVID-19, which usually presents at the severe stage. In patients with COVID-19, attention should be paid to the onset of thrombosis, even with mild respiratory infection. We also suggest that patients with thrombosis should be suspected of having COVID-19 even in the absence of respiratory infectious symptoms in a situation of COVID-19 epidemic.
format Online
Article
Text
id pubmed-8648520
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nagoya University
record_format MEDLINE/PubMed
spelling pubmed-86485202021-12-15 A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction Asano, Yuki Koshi, Tomomichi Sano, Asami Maruno, Takashi Kosaka, Makoto Yamazaki, Yoshitaka Oiwa, Ako Nishii, Yutaka Nagoya J Med Sci Case Report A 76-year-old woman was admitted to the emergency room of Nagano Municipal Hospital with the complain of severe back pain. Chest and abdominal enhanced computed tomography scans showed bilateral adrenal infarction and minute pulmonary nodules, but she had no respiratory symptoms. After admission, a family member of the patient was found to have been in close contact with a coronavirus disease 2019 (COVID-19) patient. Thus, polymerase chain reaction and antigen tests of severe acute respiratory syndrome coronavirus 2 were conducted, and both tests returned positive. D-dimer levels were normal on admission but increased 2 days thereafter. Anticoagulation therapy and steroid replacement were started, and the patient improved over about two weeks. One month after the onset of adrenal infarction, a rapid adrenocorticotropic hormone loading test was conducted, which revealed that the primary adrenal insufficiency due to adrenal infarction might have been caused by the COVID-19 infection. This case was rare and suggestive of adrenal infarction with COVID-19, which usually presents at the severe stage. In patients with COVID-19, attention should be paid to the onset of thrombosis, even with mild respiratory infection. We also suggest that patients with thrombosis should be suspected of having COVID-19 even in the absence of respiratory infectious symptoms in a situation of COVID-19 epidemic. Nagoya University 2021-11 /pmc/articles/PMC8648520/ /pubmed/34916731 http://dx.doi.org/10.18999/nagjms.83.4.883 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Case Report
Asano, Yuki
Koshi, Tomomichi
Sano, Asami
Maruno, Takashi
Kosaka, Makoto
Yamazaki, Yoshitaka
Oiwa, Ako
Nishii, Yutaka
A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction
title A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction
title_full A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction
title_fullStr A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction
title_full_unstemmed A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction
title_short A patient with mild respiratory COVID-19 infection who developed bilateral non-hemorrhagic adrenal infarction
title_sort patient with mild respiratory covid-19 infection who developed bilateral non-hemorrhagic adrenal infarction
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648520/
https://www.ncbi.nlm.nih.gov/pubmed/34916731
http://dx.doi.org/10.18999/nagjms.83.4.883
work_keys_str_mv AT asanoyuki apatientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT koshitomomichi apatientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT sanoasami apatientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT marunotakashi apatientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT kosakamakoto apatientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT yamazakiyoshitaka apatientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT oiwaako apatientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT nishiiyutaka apatientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT asanoyuki patientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT koshitomomichi patientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT sanoasami patientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT marunotakashi patientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT kosakamakoto patientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT yamazakiyoshitaka patientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT oiwaako patientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction
AT nishiiyutaka patientwithmildrespiratorycovid19infectionwhodevelopedbilateralnonhemorrhagicadrenalinfarction